Skip to main content
LpxH targeting antibiotics for Gram-negative bacteria

LpxH targeting antibiotics for Gram-negative bacteria

Unmet Need Antimicrobial resistance of bacteria to antibiotics is a major threat to public health. In 2019, 4.95 million deaths, 64% of all bacterial infection related deaths globally, were attributed to antimicrobial resistance to antibiotics.…

Read More

Antimicrobial prochelators to target drug-resistant bacteria

Antimicrobial prochelators to target drug-resistant bacteria

Value Proposition According to the CDC, each year 2.8 million people in the United States develop an antibiotic-resistant infection, leading to more than 35,000 deaths. Beta lactams were the largest segment in the antibiotics market…

Read More

Compositions and methods for treating gram-negative bacterial infection

Compositions and methods for treating gram-negative bacterial infection

Value Proposition Antimicrobial resistance is considered to be one of the biggest crises facing modern medicine today. Without desperately needed intervention, it is estimated that by 2050 over 10 million deaths per year will be…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us